Antibody Engineering of Drugs to New Treatments
-
Chair(s):
Ahuva Nissim,
Prof in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom -
Session description:
Targeting Drugs by Diseased Tissue Specific Antibody
Professor Ahuva Nissim
Proessorf in Antibody and Therapeutic Engineering, Queen Mary University, London, United KingdomSubcellular Trafficking Pathways as Targets for the Design of Therapies for Autoimmunity and Cancer
Professor Sally Ward
Professor of Molecular Immunology and Director of Translational Immunology, University of Southampton, Southampton, United KingdomOral communication speaker - to be confirmed in 2023.
New technology developments for future (Multispecific) antibody discovery and optimization
Dr Rene Hoet
Chief Innovation Officer, FairJourney Biologics, Porto Portugal & Prof. Biopharmaceutics, University Maastricht, The NetherlandsTwist Bioscience anti-SARS-CoV-2 antibodies
Dr Gary Merry
Twist Bioscience, San Francisco, The United States of America
Speakers
-
Dr Garry MerryTwist Bioscience, San Fransisco, The United States of America
-
Professor Ahuva NissimProfessor in Antibody and Therapeutic Engineering, Queen Mary University, London, United Kingdom
-
Professor Sally WardProfessor of Molecular Immunology and Director of Translational Immunology, University of Southampton, Southampton, United Kingdom
-
Rene Hoet (PhD)Chief Innovation Officer, FairJourney Biologics, Porto Portugal & Prof. Biopharmaceutics, University Maastricht, The Netherlands